Puriblood Medical Co., Ltd. (TPEX:6847)

Puriblood Medical Statistics

Total Valuation

TPEX:6847 has a market cap or net worth of TWD 1.05 billion. The enterprise value is 1.03 billion.

Market Cap	1.05B
Enterprise Value	1.03B

Important Dates

The next estimated earnings date is Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6847 has 14.23 million shares outstanding.

Current Share Class	14.23M
Shares Outstanding	14.23M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.35%
Owned by Institutions (%)	6.62%
Float	6.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.99
PB Ratio	6.45
P/TBV Ratio	6.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-137.70
EV / Sales	8.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-41.44

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.34.

Current Ratio	2.81
Quick Ratio	1.77
Debt / Equity	0.34
Debt / EBITDA	6.76
Debt / FCF	-2.21
Interest Coverage	0.19

Financial Efficiency

Return on equity (ROE) is -4.50% and return on invested capital (ROIC) is 0.12%.

Return on Equity (ROE)	-4.50%
Return on Assets (ROA)	0.04%
Return on Invested Capital (ROIC)	0.12%
Return on Capital Employed (ROCE)	0.08%
Weighted Average Cost of Capital (WACC)	3.95%
Revenue Per Employee	2.67M
Profits Per Employee	-169,750
Employee Count	44
Asset Turnover	0.47
Inventory Turnover	1.37

Taxes

Income Tax	-952,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.90% in the last 52 weeks. The beta is -0.03, so TPEX:6847's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-25.90%
50-Day Moving Average	72.53
200-Day Moving Average	76.20
Relative Strength Index (RSI)	50.01
Average Volume (20 Days)	23,959

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6847 had revenue of TWD 117.35 million and -7.47 million in losses. Loss per share was -0.53.

Revenue	117.35M
Gross Profit	64.50M
Operating Income	166,000
Pretax Income	-8.42M
Net Income	-7.47M
EBITDA	6.65M
EBIT	166,000
Loss Per Share	-0.53

Balance Sheet

The company has 80.75 million in cash and 54.78 million in debt, with a net cash position of 25.97 million or 1.82 per share.

Cash & Cash Equivalents	80.75M
Total Debt	54.78M
Net Cash	25.97M
Net Cash Per Share	1.82
Equity (Book Value)	163.38M
Book Value Per Share	11.48
Working Capital	85.87M

Cash Flow

In the last 12 months, operating cash flow was -23.73 million and capital expenditures -1.09 million, giving a free cash flow of -24.82 million.

Operating Cash Flow	-23.73M
Capital Expenditures	-1.09M
Free Cash Flow	-24.82M
FCF Per Share	-1.74

Margins

Gross margin is 54.97%, with operating and profit margins of 0.14% and -6.36%.

Gross Margin	54.97%
Operating Margin	0.14%
Pretax Margin	-7.18%
Profit Margin	-6.36%
EBITDA Margin	5.66%
EBIT Margin	0.14%
FCF Margin	n/a

Dividends & Yields

TPEX:6847 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.71%
FCF Yield	-2.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6847 has an Altman Z-Score of 9.59 and a Piotroski F-Score of 3.

Altman Z-Score	9.59
Piotroski F-Score	3